SLC17A5, solute carrier family 17 member 5, 26503

N. diseases: 252; N. variants: 47
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.050 Biomarker group BEFREE In a subgroup analysis, a higher proportion of patients with diabetes had deterioration in AST and ALT. 31409405 2019
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.050 AlteredExpression group BEFREE To investigate whether the relationship between body mass index (BMI) and incident diabetes is modified by different alanine or aspartate aminotransferases (ALT or AST) levels. 30075987 2018
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.050 GeneticVariation group BEFREE We retrospectively studied SF and post-screening age; sex; body mass index; transferrin saturation (TS); ALT; AST; GGT; elevated C-reactive protein; ß-thalassemia; neutrophils; lymphocytes; monocytes; platelets; metacarpophalangeal joint hypertrophy; hepatomegaly; splenomegaly; diabetes; HFE H63D positivity; iron/alcohol intakes; and blood/erythrocyte transfusion units. 28809726 2018
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.050 AlteredExpression group BEFREE Compared with the control group, glucose, triglycerides, total cholesterol, AST, ALT, BUN, fasting insulin and homeostatic model assessment insulin resistance levels in peripheral blood were significantly increased in the diabetes group. 29213335 2017
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.050 Biomarker group BEFREE In addition, for G1, Black race, Hispanic ethnicity, aspartate aminotransferase/alanine aminotransferase (AST/ALT) ≥ 0.6, ferritin ≥ 350 ng/mL, LDL< 100 mg/dL and diabetes; for G2, BMI ≥ 30 kg/m(2), platelets < 150 K/μL, LDL< 100 mg/dL and the use of PEG-IFN alfa-2b; and for G3, AST/ALT ≥ 1.0, all negatively predicted rapid virological response. 22060887 2012